Company Search:
Advanced Search
Sponsored Links
Fuso Pharmaceutical Industries Ltd Company Snapshot
Fuso Pharmaceutical Industries Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fuso Pharmaceutical Industries Ltd with three other companies in this sector in JAPAN : Aska Pharmaceutical Company Limited (2020 sales of 52.54 billion Japanese Yen [US$497.05 million] of which 91% was Pharmaceutical Products Business), Zeria Pharmaceutical Co Ltd (60.43 billion Japanese Yen [US$571.64 million] of which 53% was Pharmaceuticals Business), and Eiken Chemical Co., Ltd. (36.59 billion Japanese Yen [US$346.09 million] of which 55% was Immunoserology Test Agent).

Sales Analysis. During the year ended March of 2020, sales at Fuso Pharmaceutical Industries Ltd were ¥46.90 billion (US$443.68 million). This is a very small increase of 1.8% versus 2019, when the company's sales were ¥46.07 billion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Fuso Pharmaceutical Industries Ltd had sales of ¥47.04 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Fuso Pharmaceutical Industries Ltd
  Stock Performance Chart for Fuso Pharmaceutical Industries Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 2,266.00
(Figures in Japanese Yen )
1 Week -5.6%   13 Weeks -2.7%  
4 Weeks 1.3%   52 Weeks 20.7%  
Fuso Pharmaceutical Industries Ltd Key Data:
  Ticker: 4538 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 46,901,000,000
(Year Ending Jan 2021).
Employees: 1,352
  Currency: Japanese Yen Market Cap: 19,882,538,874
  Fiscal Yr Ends: March Shares Outstanding: 8,774,289
  Share Type: Common Closely Held Shares: 1,724,974
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.